VERIMMUNE
Live / Registered — Registered (as of 19 Jul 2022)
What this means for you
Registered since 19 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88809441
- Registration number
- 6798303
- Mark type
- Stylized text
- Filed
- 25 Feb 2020
- Published for opposition
- 16 Mar 2021
- Registered
- 19 Jul 2022
- Attorney of record
- Joanna T. Brougher
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical research, namely, developing immune modulators for the prevention and treatment of cancer and tumors; research and development in the field of pharmaceutical preparations for immune modulators for the prevention and treatment of cancer and tumors
Owner
- VERIMMUNE INC., WILMINGTON, DE, US
- VerImmune Inc., Washington, DC, US
- VerImmune Inc., Washington, DC, US
- VerImmune Inc., Baltimore, MD, US
Prosecution history
- 01 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jun 2022 — ASSIGNED TO EXAMINER
- 16 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 04 May 2022 — USE AMENDMENT FILED
- 13 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 13 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Nov 2021 — SOU EXTENSION 1 GRANTED
- 11 Nov 2021 — SOU EXTENSION 1 FILED
- 11 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 11 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT